NRG1
Pro-neuregulin-1, membrane-bound isoform
Also known as: GGF, HGL, HRG, NDF, NRG1_HUMAN, NRG1-IT2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q02297
- Gene
- NRG1
- Ensembl
- ENSG00000157168
- Chromosome
- 8
- Canonical length
- 640 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is a membrane glycoprotein that mediates cell-cell signaling and plays a critical role in the growth and development of multiple organ systems. An extraordinary variety of different isoforms are produced from this gene through alternative promoter usage and splicing. These isoforms are expressed in a tissue-specific manner and differ significantly in their structure, and are classified as types I, II, III, IV, V and VI. Dysregulation of this gene has been linked to diseases such as cancer, schizophrenia, and bipolar disorder (BPD). [provided by RefSeq, Apr 2016]
Canonical amino-acid sequenceUniProt
640 residues, UniProt reviewed canonical sequence.
>Q02297|NRG1
1 MSERKEGRGK GKGKKKERGS GKKPESAAGS QSPALPPRLK EMKSQESAAG SKLVLRCETS
61 SEYSSLRFKW FKNGNELNRK NKPQNIKIQK KPGKSELRIN KASLADSGEY MCKVISKLGN
121 DSASANITIV ESNEIITGMP ASTEGAYVSS ESPIRISVST EGANTSSSTS TSTTGTSHLV
181 KCAEKEKTFC VNGGECFMVK DLSNPSRYLC KCQPGFTGAR CTENVPMKVQ NQEKAEELYQ
241 KRVLTITGIC IALLVVGIMC VVAYCKTKKQ RKKLHDRLRQ SLRSERNNMM NIANGPHHPN
301 PPPENVQLVN QYVSKNVISS EHIVEREAET SFSTSHYTST AHHSTTVTQT PSHSWSNGHT
361 ESILSESHSV IVMSSVENSR HSSPTGGPRG RLNGTGGPRE CNSFLRHARE TPDSYRDSPH
421 SERYVSAMTT PARMSPVDFH TPSSPKSPPS EMSPPVSSMT VSMPSMAVSP FMEEERPLLL
481 VTPPRLREKK FDHHPQQFSS FHHNPAHDSN SLPASPLRIV EDEEYETTQE YEPAQEPVKK
541 LANSRRAKRT KPNGHIANRL EVDSNTSSQS SNSESETEDE RVGEDTPFLG IQNPLAASLE
601 ATPAFRLADS RTNPAGRFST QEEIQARLSS VIANQDPIAVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NRG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- liver: 16 nTPM
- retina: 11 nTPM
- hypothalamus: 9.9 nTPM
- thyroid gland: 9 nTPM
- urinary bladder: 8.6 nTPM
- kidney: 7.8 nTPM
Single-cell type
- lactotrophs: 7,015 nCPM
- retinal horizontal cells: 4,492 nCPM
- thyrotrophs: 4,198 nCPM
- retinal ganglion cells: 2,009 nCPM
- somatotrophs: 1,927 nCPM
- gonadotrophs: 1,913 nCPM
Immune cell
- classical monocyte: 54 nTPM
- total PBMC: 14 nTPM
- myeloid DC: 12 nTPM
- intermediate monocyte: 4.7 nTPM
- neutrophil: 1.9 nTPM
- eosinophil: 0.9 nTPM
Brain region
- pons: 87 nTPM
- medulla oblongata: 61 nTPM
- cerebral cortex: 39 nTPM
- hypothalamus: 39 nTPM
- cerebellum: 31 nTPM
- white matter: 29 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NRG1.
Disease | ImmuneIEDB
Conditions an epitope on NRG1 was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.64
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activation of protein kinase B activity
- brain development
- cardiac muscle cell differentiation
- cardiac muscle cell myoblast differentiation
- cell communication
- cell differentiation
- cell population proliferation
- cell surface receptor protein tyrosine kinase signaling pathway
- endocardial cell differentiation
- ERBB signaling pathway
- ERBB2 signaling pathway
- ERBB2-ERBB3 signaling pathway
- ERBB2-ERBB4 signaling pathway
- ERBB4 signaling pathway
- ERBB4-ERBB4 signaling pathway
- intracellular signal transduction
- mammary gland development
- negative regulation of cardiac muscle cell apoptotic process
- negative regulation of DNA-templated transcription
- negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
- negative regulation of secretion
- nervous system development
- neural crest cell development
- peripheral nervous system development
- positive regulation of cardiac muscle cell proliferation
- positive regulation of cell adhesion
- positive regulation of cell growth
- positive regulation of cell population proliferation
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of protein-containing complex assembly
- positive regulation of striated muscle cell differentiation
- regulation of postsynaptic neurotransmitter receptor internalization
- ventricular cardiac muscle cell differentiation
- ventricular trabecula myocardium morphogenesis
- wound healing
- ERBB3 signaling pathway
- positive regulation of peptidyl-tyrosine autophosphorylation
Molecular functions
- chemorepellent activity
- cytokine activity
- ErbB-3 class receptor binding
- growth factor activity
- integrin binding
- nickel cation binding
- protein tyrosine kinase activator activity
- receptor ligand activity
- receptor tyrosine kinase binding
- signaling receptor binding
- transcription coregulator activity
- transmembrane receptor protein tyrosine kinase activator activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NRG1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NRG1 as an antibody target. Whether an autoantibody or antibody against NRG1 could matter depends on whether native NRG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NRG1 is annotated at the cell surface, where native NRG1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NRG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...